Development of Hashimoto's disease in patients with vitiligo
DOI:
https://doi.org/10.12775/QS.2024.28.55360Keywords
Hashimoto's disease, vitiligo, epidemiology, pathogenetic mechanismAbstract
The aim of this paper is to review the available scientific literature on the relationship between vitiligo and the development of Hashimoto's disease, with particular emphasis on possible pathogenetic mechanisms and clinical implications of this correlation. The relationship between vitiligo and thyroid diseases, especially Hashimoto's disease, has intrigued researchers for years. Numerous clinical observations suggested that patients with vitiligo more often struggle with thyroid problems, but only extensive epidemiological studies allowed for a precise estimate of the scale of this phenomenon.
References
Caturegli, P., De Remigis, A., & Rose, N. R. (2014). Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity Reviews, 13(4-5), 391-397.
Gey, A., Diallo, A., Seneschal, J., Léauté-Labrèze, C., Boralevi, F., Jouary, T., Taieb, A., & Ezzedine, K. (2013). Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. British Journal of Dermatology, 168(4), 756-761.
Gill, L., Zarbo, A., Isedeh, P., Jacobsen, G., Lim, H. W., & Hamzavi, I. (2016). Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. Journal of the American Academy of Dermatology, 74(2), 295-302.
Harris, J. E., Harris, T. H., Weninger, W., Wherry, E. J., Hunter, C. A., & Turka, L. A. (2012). A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin. Journal of Investigative Dermatology, 132(7), 1869-1876.
Karagün, E., Ergin, C., Baysak, S., Erden, G., Aktaş, H., & Ekiz, Ö. (2016). The role of serum vitamin D levels in vitiligo. Advances in Dermatology and Allergology/Postȩpy Dermatologii I Alergologii, 33(4), 300-302.
Kasumagic-Halilovic, E., Prohic, A., Begovic, B., & Ovcina-Kurtovic, N. (2011). Association between vitiligo and thyroid autoimmunity. Journal of Thyroid Research, 2011, 938257.
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., Harris, J. E., & Vitiligo Working Group (2017). New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology, 77(1), 1-13.
Spritz, R. A. (2010). The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Medicine, 2(10), 78.
Taieb, A., Picardo, M., & VETF Members (2020). The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell & Melanoma Research, 33(1), 27-35.
van Driessche, F., Silverberg, N., & Polak, M. (2009). Thyroid disorders and vitiligo in children and adolescents: a prospective study. Journal of the American Academy of Dermatology, 60(3), AB160.
Wang, J., Lv, S., Chen, G., Gao, C., He, J., Zhong, H., & Xu, Y. (2015). Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients, 7(4), 2485-2498.
Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A., & Fallahi, P. (2015). Autoimmune thyroid disorders. Autoimmunity Reviews, 14(2), 174-180.
Colucci, R., Lotti, F., Dragoni, F., Arunachalam, M., Lotti, T., Benvenga, S., & Moretti, S. (2015). High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. British Journal of Dermatology, 173(3), 786-791.
Craiglow, B. G., & King, B. A. (2019). Tofacitinib for the treatment of vitiligo: A review of the literature. Journal of Drugs in Dermatology, 18(9), 937-940.
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015). Vitiligo. The Lancet, 386(9988), 74-84.
Gey, A., Diallo, A., Seneschal, J., Léauté-Labrèze, C., Boralevi, F., Jouary, T., ... & Taieb, A. (2013). Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. British Journal of Dermatology, 168(4), 756-761.
Krüger, C., & Schallreuter, K. U. (2012). A review of the worldwide prevalence of vitiligo in children/adolescents and adults. International Journal of Dermatology, 51(10), 1206-1212.
Silverberg, J. I., Lebwohl, M., Silverberg, N. B., Rosmarin, D., Rastogi, S., Tsoukas, M. M., ... & King, B. (2018). Association of vitiligo with hospitalization for mental health disorders in US adults. Journal of the European Academy of Dermatology and Venereology, 33(1), 191-197.
Tanner, K. L., Spierings, E. L., & Hahn, R. G. (2018). Thyroid disease in patients with vitiligo: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 79(3), 552-555.
Vrijman, C., Kroon, M. W., Limpens, J., Leeflang, M. M., Luiten, R. M., van der Veen, J. P., ... & Spuls, P. I. (2012). The prevalence of thyroid disease in patients with vitiligo: a systematic review. British Journal of Dermatology, 167(6), 1224-1235.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jakub Paprocki, Anna Mataczyńska, Michał Paprocki, Mateusz Dobosz, Klaudia Arciszewska, Anna Szpernalowska, Vimbisoyashe Ivy Matshaba, Karolina Mrugała, Martyna Choinka, Jakub Kalisiak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 266
Number of citations: 0
